DOCSLIB.ORG

The Adverse Health Effects of Smoking and the Tobacco Industry’S Efforts to Limit Tobacco Control

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Adverse Health Effects of Smoking and the Tobacco Industry’S Efforts to Limit Tobacco Control THE ADVERSE HEALTH EFFECTS OF SMOKING AND THE TOBACCO INDUSTRY’S EFFORTS TO LIMIT TOBACCO CONTROL Prepared by: Jonathan M. Samet, MD, MS Director, USC Institute for Global Health Distinguished Professor and Flora L. Thornton Chair, Department of Preventive Medicine, Keck School of Medicine of USC University of Southern California 2001 North Soto Street, Suite 330A Los Angeles, California 90089-9239, USA Phone: +1 323 865 0803 Fax: +1 323 865 0854 Email: [email protected] 1 Table of Contents Summary ....................................................................................................................................................... 4 Professional Qualifications ........................................................................................................................... 6 Approach ....................................................................................................................................................... 9 Introduction and Context ............................................................................................................................ 10 Scientific approaches to smoking and health ......................................................................................... 11 Epidemiological research ........................................................................................................................ 14 Identifying causes of disease................................................................................................................... 15 The identification of the risks of smoking—a century-long perspective ................................................. 17 Evidence-based and evidence-driven tobacco control and its consequences ......................................... 20 Tobacco Industry Actions ............................................................................................................................ 23 Long-standing goal of maintaining/expanding market .......................................................................... 23 Long-standing industry concern about litigation risk because of the deadly risks of its products ......... 24 Health Effects of Active Smoking ................................................................................................................ 26 Emergence of the evidence on smoking and health ............................................................................... 26 The tobacco industry response ............................................................................................................... 27 The 1964 Surgeon General’s report ........................................................................................................ 29 Nicotine Addiction ...................................................................................................................................... 31 Background ............................................................................................................................................. 31 Long-standing industry understanding of role of nicotine and the need to deliver a sufficient nicotine dosage ..................................................................................................................................................... 32 Industry use of ammonia technology to enhance nicotine delivery ....................................................... 34 Other strategies: portraying cigarette smoking as a “choice” and a ”right” .......................................... 35 The 1988 Surgeon General’s report ........................................................................................................ 36 Secondhand Smoke (SHS) ........................................................................................................................... 37 Industry recognition of the critical implications of findings on SHS ........................................................ 37 Emerging evidence on adverse consequences of SHS ............................................................................. 39 Industry responses to evidence on SHS ................................................................................................... 41 • Tactics related to exposure studies ......................................................................................... 41 • Tactics related to epidemiological studies .............................................................................. 42 • Strategies related to expert reports ......................................................................................... 43 • Tactics to limit indoor smoking bans ....................................................................................... 45 2 Light and Low-Tar Cigarettes ...................................................................................................................... 46 Filter cigarettes: the campaign begins .................................................................................................... 47 Implementation of the FTC protocol; misleading numbers ..................................................................... 47 The Success of the Tobacco-Industry Playbook .......................................................................................... 52 References .................................................................................................................................................. 53 3 Summary I have been asked by the law firm Foley Hoag LLP to provide an expert report concerning the evolution of understanding of the adverse consequences of tobacco use and the tobacco industry’s history of misleading the public, including public health authorities, about the adverse health effects of smoking. I understand that this report will be submitted in connection with Uruguay’s pleadings in the investment arbitration brought against it by certain affiliates of the Philip Morris International family of companies. In this report, I provide a broad review of the identification of the adverse health consequences of active and passive smoking; the resulting efforts to control tobacco use; and the tobacco industry’s many efforts to thwart tobacco control. While its focus is on the United States, where this history is best documented, the tactics used in the United States have been used widely by the multi-national tobacco companies, including by Philip Morris. This report describes many of those tactics, which have included: 1) creating uncertainty concerning the scientific foundation of public health action; 2) misinforming and misleading the public concerning the harms of its products; and 3) continually and aggressively attempting to counter efforts to control tobacco use. These various efforts were well funded and often involved activities based in illegal collusion among the companies and fraudulent representations. These tactics delayed and weakened tobacco control, resulting in premature mortality, and additional disease and mortality that could have been avoided. I begin by outlining my professional qualifications and my extensive experience in research on the health risks of smoking and in tobacco control throughout my career (page 6). I note the approach I have taken in developing this report (page 9). In the first section, Introduction and Context, I provide a background on the scientific methods used to establish the harms of smoking and the development of evidence-based approaches to tobacco control (page 10). I follow by highlighting the actions taken by the tobacco industry to maintain smoking and advance sales of its tobacco products by attempting to counter tobacco control efforts (page 23). I then describe the health effects of active smoking (page 26). In the next section, Nicotine Addiction, I provide background on nicotine as the agent of addiction and the cigarette as an effective delivery device for nicotine (page 31). I detail the role that the tobacco industry has long played in sustaining nicotine addiction through tobacco product design and manipulation, while discrediting the scientific evidence that tobacco products and nicotine are addicting. Following this section, I describe the critical findings on the adverse health effects of secondhand smoke exposure, and the tobacco industry’s decades- long strategies and diverse tactics used in an effort to counter the tobacco control implications of 4 the evidence on secondhand smoke (page 37). Next, I outline one of the tobacco industry’s efforts to counter the rising concerns about risks of smoking cigarettes: by designing and manufacturing cigarettes that were marketed as having lesser health risks—the so-called light and low-tar cigarettes—and thus the industry’s deliberate efforts to misinform and mislead the public (page 47). I conclude this report by summarizing the aggressive actions employed by the tobacco industry over the last seven decades to blunt efforts to curb tobacco use in the face of mounting scientific evidence on the health consequences of active and passive smoking (page 52). 5 Professional Qualifications My education and training is in medicine (internal medicine and pulmonary disease) and public health, specifically the discipline of epidemiology (see attached curriculum vitae). I received an A.B. degree from Harvard College in Chemistry and Physics in 1966 and then received my M.D. degree from the University of Rochester School of Medicine and Dentistry in 1970. Training after medical school included completion
Load more

Recommended publications
  • Richard Doll
    2825 Obituary: Richard Doll Sir Richard Doll died earlier this year at age 92. The most The studies by Doll are bold and original science. They celebrated epidemiologist of the 20th century, Doll is best represent an important part of the foundation of modern known for his work on smoking and lung cancer, but there was population-based chronic disease research. By the early 1960s, so much more to his career. they constituted adequate evidence for public health action to His father was a general practitioner in London, and it was reduce tobacco smoking; in 1964, the U.S. Surgeon General’s from St. Thomas’s that Doll himself graduated in Medicine in first report on the adverse health consequences of tobacco was 1937. Even as a student, he showed his interest in epidemi- published. Today, they continue to remind us how carefully ologic and statistical tools, publishing on the need for proper crafted observational studies can advance scientific knowledge analysis and statistical testing in population studies of disease. regarding social and health issues that are not amenable to Later, Doll served in the Royal Medical Corps in France and experimentation on human populations. the Middle East throughout the Second World War. He began Asbestos. By the early 1930s, work in the asbestos products his research career at the Middlesex Hospital, studying industry in Britain was known to increase the risk of a occupational factors in the development of peptic ulceration. sometimes fatal nonmalignant pulmonary disease, termed He married Dr. Joan Faulkner around this time, and it was she asbestosis.
    [Show full text]
  • Date of Preparation October 1, 2020 Format of This CV: Committee On
    Date of Preparation October 1, 2020 Format of this CV: Committee on Appointments and Promotions Mailman School of Public Health, Columbia University Personal data Steven D. Stellman Birthdate: May 7, 1945 Birthplace: Toronto, Canada Citizenship: USA Academic appointments 1966-71 Teaching Fellow, Department of Chemistry, New York University 1971-73 Research Associate, Division of Biochemical Sciences, Princeton University 1973-74 Lecturer in Chemistry, University of Colorado, Denver 1978-82 Adjunct Associate Professor, Hunter College of the City University of New York, Depts. of Chemistry and Environmental Health Sciences 1979-82 Adjunct Associate Professor, Dept. of Research Medicine, University of Pennsylvania School of Medicine 1980-81 Adjunct Associate Professor, Dept. of Epidemiology, Cornell University School of Medicine 1981-94 Adjunct Associate Professor, Dept. of Community Medicine, Mt. Sinai School of Medicine, New York, NY 2000 - Professor of Clinical Epidemiology, Mailman School of Public Health, Columbia University; Assoc Chair, 2016- Education Ohio State University, B.Sc. 09/1964 to 06/1966, Chemistry. New York University, Ph.D. 09/1966 to 1971, Physical chemistry. Thesis title: Computer simulation of polymer conformation and conformational thermodynamics. Sponsor: Paul J. Gans, Ph.D. Citations: (1) Stellman SD, Froimowitz M, Gans PJ. J Computational Physics 1971; 7:179-182. (2) Stellman SD, Gans PJ. Macromolecules 1972; 5:516-526. (3) Stellman SD, Gans PJ. Macromolecules 1972; 5:720-729. Columbia University, M.P.H., 09/1990 to 06/1992, Executive MPH Program in Health Policy & Management Traineeships 1968-71 New York University, National Science Foundation Graduate Traineeship 1971-73 Princeton University, Post-doctoral fellow, Dept. of Biochemical Sciences Professional organizations and societies Society for Epidemiologic Research American College of Epidemiology American Public Health Association American Chemical Society American Society of Preventive Oncology Steven D.
    [Show full text]
  • PL 43 Coût Des Soins De Santé Et Des Dommages- Intérêts Liés Au Tabac
    CAS – 001M C.P. – P.L. 43 Coût des soins de santé et des dommages- intérêts liés au tabac Le 9 juin 2009 Monsieur Geoffrey Kelley Président Commission des affaires sociales Assemblée nationale Québec (Québec) G1A 1A3 Objet : Le projet de loi 43 : Loi sur le recouvrement du coût des soins de santé et des dommages-intérêts liés au tabac Monsieur le président, Au nom de l’Association pour les droits des non-fumeurs, je vous remercie beaucoup de l’occasion que vous nous offrez de témoigner devant vous sur le projet de loi 43 : la Loi sur le recouvrement du coût des soins de santé et des dommages-intérêts liés au tabac. Je vous félicite pour la décision de vous joindre aux autres provinces et territoires au Canada et d’entreprendre des démarches afin de tenir responsable les principaux fabricants de tabac au pays, non seulement pour avoir manqué à leur obligation d’informer le public sur la nocivité de leurs produits, mais surtout pour avoir mis en œuvre une vaste conspiration visant à jeter le doute au sein des législateurs et du public sur les véritables dangers de l’usage du tabac. À notre avis, cette initiative ne vise pas à savoir si les fabricants de tabac ont commis ou non une telle fraude mais plutôt de connaître l’ampleur de celle-ci. Il suffit simplement de jeter un coup d’œil aux documents publiés à ce jour par différentes instances juridiques pour comprendre que la communauté de la santé, dont nous faisons partie, n’exagère en rien lorsqu’elle qualifie d’odieux le comportement de l’industrie du tabac au Canada.
    [Show full text]
  • 1 Rylander Affair Professor Ragnar Rylander Was a Member of The
    Rylander Affair Professor Ragnar Rylander was a member of the faculty at the University of Geneva who did extensive research funded by the tobacco industry. After litigation Rylander lost against two tobacco control advocates (for defamation), the University conducted the equivalent of a UC Privilege and Tenure Hearing. The report was made public. In contrast the to unwillingness of UCORP and others at UC, the Committee viewed the issues in the broader context. As a result of this recommendation, the President of the University of Geneva announced that the university would not longer accept money from the tobacco industry. Here is an announcement of the decision and some associated links: Geneva, Friday October 29, 2004 16h00 local time The University of Geneva just made public a few hours ago its report on the "Affaire Rylander". Here are two excerpts of the summary (translation by PAD), which set the tone of the whole report. "The scientific community and the public must know that Ragnar Rylander's studies on the effects of environmental tobacco smoke on health are marred with serious suspicion, because the author has not revealed his conflicts of interest which were susceptible of influencing the significance of these studies and because he cannot be considered as an independent scientist, considering his role as secret employee of the tobacco industry. The Fact Finding Commission proposes that the following journals be notified of this situation: - European Journal of Public Health; - Archives of Environmental Health; -International Journal of Epidemiology" "Prof. Rylander's multiple breaches of scientific integrity take their full significance only when placed in the framework of the strategy conceived and carried out by the tobacco industry to throw doubt on the toxicity of tobacco smoke, particularly for the non-smokers.
    [Show full text]
  • Motor Vehicle Air Pollution
    wHotPEPt92.4 Distr:Limited Original:English Motor Vehicle Air Pollution Public Health Impact and Control Measures Editedby David Mage and Olivier Zali Division of EnvironmentalHealth EcotoxicologyService World HealthOrganization Departmentof PublicHealth Geneva,Switzedand Republicand Cantonof Geneva Geneva,Switzerland @ World HealthOrganization and ECOTOX ,lgg2 This documentis not issuedto the generalpublic, and all rights are reservedby the World HealthOrganization (WHO) andthe Serviceof Ecotoxicology (ECOTOX)of the Departmentof PublicHealth, Geneva. The documentmay be reviewed,abstracted, quoted, reproduced or translated,in part or in whole, with the prior written permissionof WHO or ECOTOX. Partsof this documentmay be storedin a retrievalsystem or transmittedin any form or by any means- electronic,mechanical or other- with the prior written permissionof WHO or ECOTOX. The views expressedin the documentby namedauthors are solelythe responsibilityof thoseauthors. The geographicaldesignations employed and the presentationof materialin this documentdo not imply the expressionof any opinionwhatsoever on the part of WHO concerningthe legal statusof any country,territory, city or areaof its authorities,or concerningthe delimitationof its frontiersor boundaries. Credits:cover photograph of Genevaby E.J. Aldag @.J. Press),Geneva; cover photographof Mexico City by ASL, Lausanne;stamp design, copyright Sweden PostStamps. MOTOR VEHICLE AIR POLLUTION PTJBLICHEALTII IMPACT AND CONTROLMEASURES Contents Page Foreword- Wilfried Kreiseland Guy-OlivierSegond v Executivesummary vii 1.Introduction.... 1 2. Review of the health effectsof motor vehicle traffic . 13 - Part I. Epidemiologicalstudies of the healtheffects of air pollutiondue to motorvehicles - IsabelleRomieu 13 - Part II. Effectson humansof environmentalnoise particutarly from road traffic - RagnarRylander 63 3. Humanexposure to motor vehicleair pollutants- PeterG. Flachsbart 85 4. Reviewof motor vehicleemission control mqNures andtheir effectiveness- Michael P. Walsh 115 5.
    [Show full text]
  • The P53 Tumour Suppressor Gene and the Tobacco Industry
    Lancet Manuscript 03ART/3495 Revised 1 The p53 Tumor Suppressor Gene and the Tobacco Industry: Research, Debate, and Conflict of Interest Asaf Bitton, BA Mark D. Neuman, BA Joaquin Barnoya, MD MPH Stanton A. Glantz, PhD Center for Tobacco Control Research and Education University of California, San Francisco San Francisco, CA 94143 This work was supported by National Cancer Institute Grant CA-87472 and the American Legacy Foundation. Address for correspondence and Reprints: Stanton A. Glantz, PhD Professor of Medicine Box 1390 University of California San Francisco, CA 94143 415-476-3893 fax 415-514-9345 [email protected] Lancet Manuscript 03ART/3495 Revised 2 Summary Background: Mutations in the p53 tumor suppressor gene lead to uncontrolled cell division and are found in over 50% of all human tumors, including 60% of lung cancers. Research published in 1996 by Mikhail Denissenko et al. demonstrated patterned in vitro mutagenic effects on p53 of benzo[a]pyrene, a carcinogen present in tobacco smoke. We investigate the tobacco industry’s strategies in responding to p53 research linking smoking to cancer. Methods: We searched online tobacco document archives, including the Legacy Tobacco Documents Library and Tobacco Documents Online, and archives maintained by tobacco companies such as Philip Morris and RJ Reynolds. Documents were also obtained from the British American Tobacco Company depository near Guildford, England. Informal correspondence was carried out with scientists, lawyers, and tobacco control experts in the United States and Europe. Findings: Individuals at the highest levels of the tobacco industry anticipated and carefully monitored p53 research. Tobacco scientists conducted research intended to cast doubt on the link between smoking and p53 mutations.
    [Show full text]
  • Advances in APPLIED MICROBIOLOGY
    Advances in APPLIED MICROBIOLOGY VOLUME 69 Advances in APPLIED MICROBIOLOGY VOLUME 69 Edited by ALLEN I. LASKIN Somerset, New Jersey, USA SIMA SARIASLANI Wilmington, Delaware, USA GEOFFREY M. GADD Dundee, Scotland, UK AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 32, Jamestown Road, London NW1 7BY, UK First edition 2009 Copyright # 2009 Elsevier Inc. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: [email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negli- gence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made ISBN: 978-0-12-374824-9 ISSN: 0065-2164 For information on all Academic Press publications visit our website at www.elsevierdirect.com Printed and bound in the USA 091010987654321 CONTENTS Contributors ix 1.
    [Show full text]
  • A Frank Statement to Cigarette Smokers 1
    1 A FRANK STATEMENT TO CIGARETTE SMOKERS Recent reports on experiments with mice have given wide publicity to the theory that cigarette smoking is in some way linked with lung cancer in human beings. Although conducted by doctors of professional standing, these experiments are not regarded as conclusive in the field of cancer research. However, we do not believe that any serious medical research, even though its results are inconclusive, should be disregarded or lightly dismissed. At the same time, we feel it is in the public interest to call attention to the fact that eminent doctors and research scientists have publicly questioned the claimed significance of these experiments. Distinguished authorities point out: 1. That medical research of recent years indicates many possible causes of lung cancer. 2. That there is no agreement among the authorities regarding what the cause is. 3. That there is no proof that cigarette smoking is one of the causes. 4. That statistics purporting to link cigarette smoking with the disease could apply with equal force to any one of many other aspects of modern life. Indeed, the validity of the statistics themselves is questioned by numerous scientists. We accept an interest in people’s health as a basic responsibility, paramount to every other consideration in our business. We believe the products we make are not injurious to health. We always have and always will cooperate closely with those whose task it is to safeguard the public health. For more than 300 years tobacco has given solace, relaxation and enjoyment to mankind. At one time or another during those years critics have held it responsible for practically every disease of the human body.
    [Show full text]
  • Tobacco Control
    TOBACCO CONTROL Playbook World Health Organization ABSTRACT Tobacco control is difficult and complex and obstructed by the tactics of the tobacco industry and its allies to oppose effective tobacco control measures. This document was developed by the WHO Regional Office for Europe by collecting numerous evidence-based arguments from different thematic areas, reflecting the challenges that tobacco control leaders have faced while implementing various articles of the WHO FCTC and highlighting arguments they have developed in order to counter and succeed against the tobacco industry. KEY WORDS TOBACCO CONTROL WHO FCTC HEALTH EFFECTS TOBACCO INDUSTRY ARGUMENTS © World Health Organization 2019 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.
    [Show full text]
  • Amicus Curiae Public Health Advocacy Institute in Support of Appellants
    COMMONWEALTH OF MASSACHUSETTS SUPREME JUDICIAL COURT FOR THE COMMONWEALTH OF MASSACHUSETTS No. SJC-11641 ___________________________ STEVEN P. ABDOW, STEPHANIE C. CRIMMONS, JOSEPH A. CURATONE, GERI EDDINS, MARK A. GOTTLIEB, CELESTE B. MEYERS, KRISTIAN M. MINEAU, KATHLEEN CONLEY NORBUT, JOHN F. RIBEIRO, and SUSAN C. TUCKER, Plaintiffs/Appellants v. GEORGE DUCHARME, ET AL., DANIEL RIZZO, ET AL., and DOMENIC J. SARNO, ET AL., Interveners/Appellants, v. ATTORNEY GENERAL and SECRETARY OF THE COMMONWEALTH, Defendants/Appellees. ___________________________ BRIEF OF AMICUS CURIAE PUBLIC HEALTH ADVOCACY INSTITUTE IN SUPPORT OF APPELLANTS ___________________________ Edward L. Sweda, Jr. BBO #489820 Public Health Advocacy Institute 360 Huntington Ave., 117 CU Boston, MA 02115 (617) 373-2026 Counsel for the Public Health Advocacy Institute TABLE OF CONTENTS TABLE OF AUTHORITIES................................ ii CORPORATE DISCLOSURE STATEMENT....................... 1 STATEMENT OF INTEREST OF THE AMICI CURIAE............ 1 INTRODUCTION......................................... 2 SUMMARY OF ARGUMENT.................................. 4 ARGUMENT............................................. 6 CONCLUSION.......................................... 42 CERTIFICATE OF COMPLIANCE WITH MASS. R. APP. P. 16(k) .................................................... 44 i TABLE OF AUTHORITIES Cases Aspinall v. Philip Morris Cos., Inc., 2014 Mass. Super. LEXIS 26 (Mass. 2014) ....................................................... 15 Donovan v. Philip Morris USA, Inc.,
    [Show full text]
  • AATS Graham Foundation
    AATS GRAHAM FOUNDATION 1973-2013 40YEARS OF SUPPORTING DRIVING LEADERSHIP, LEARNING AND INNOVATION IN THE PURSUIT OF EXCELLENCE 2013 ANNUAL REPORT Excellence! 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40
    [Show full text]
  • Stop Smoking Systems BOOK
    Stop Smoking Systems A Division of Bridge2Life Consultants BOOK ONE Written by Debi D. Hall |2006 IMPORTANT REMINDER – PLEASE READ FIRST Stop Smoking Systems is Not a Substitute for Medical Advice: STOP SMOKING SYSTEMS IS NOT DESIGNED TO, AND DOES NOT, PROVIDE MEDICAL ADVICE. All content, including text, graphics, images, and information, available on or through this Web site (“Content”) are for general informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis or treatment. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE, OR DELAY IN SEEKING IT, BECAUSE OF SOMETHING YOU HAVE READ IN THIS PROGRAMMATERIAL. NEVER RELY ON INFORMATION CONTAINED IN ANY OF THESE BOOKS OR ANY EXERCISES IN THE WORKBOOK IN PLACE OF SEEKING PROFESSIONAL MEDICAL ADVICE. Computer Support Services Not Liable: IS NOT RESPONSIBLE OR LIABLE FOR ANY ADVICE, COURSE OF TREATMENT, DIAGNOSIS OR ANY OTHER INFORMATION, SERVICES OR PRODUCTS THAT YOU OBTAIN THROUGH THIS SITE. Confirm Information with Other Sources and Your Doctor: You are encouraged to confer with your doctor with regard to information contained on or through this information system. After reading articles or other Content from these books, you are encouraged to review the information carefully with your professional healthcare provider. Call Your Doctor or 911 in Case of Emergency: If you think you may have a medical emergency, call your doctor or 911 immediately. DO NOT USE THIS READING MATERIAL OR THE SYSTEM FOR SMOKING CESSATION CONTAINED HEREIN FOR MEDICAL EMERGENCIES. No Endorsements: Stop Smoking Systems does not recommend or endorse any specific tests, products, procedures, opinions, physicians, clinics, or other information that may be mentioned or referenced in this material.
    [Show full text]